Form D · Venture Capital Fund
FC SmithRx Series C, LP
Newton, MA · CIK 0001996800
Offering snapshot reported Nov 16, 2023 · SEC filing
- Reported sold
- $1.55M Indefinite offering
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2023 | Initial | $1,550,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-497434
Source: Form D, filed Nov 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis Beryl | Executive |
| N/A Four Cities Fund V Gp, Llc | Executive |
| Matthew Mcknight | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
139 Gibbs Street
Newton, MA, 02459
Newton, MA, 02459